Development of novel measures for Alzheimer's disease prevention trials (NoMAD).

Authors

Sophie A Bell
Hannah R Cohen
Seonjoo Lee
Hyun Kim
Adam Ciarleglio, George Washington University
Howard Andrews
Andres M Rivera
Kay Igwe
Adam M Brickman
D P Devanand
Philip D Harvey
Lon S Schneider
Terry E Goldberg

Document Type

Journal Article

Publication Date

4-30-2021

Journal

Contemporary Clinical Trials

Volume

106

DOI

10.1016/j.cct.2021.106425

Comments

Online ahead of print

Recommended Citation

Bell, S., Cohen, H., Lee, S., Kim, H., Ciarleglio, A., Andrews, H., Rivera, A., Igwe, K., Brickman, A., Devanand, D., Harvey, P., Schneider, L., & Goldberg, T. (2021). Development of novel measures for Alzheimer's disease prevention trials (NoMAD).. Contemporary Clinical Trials, 106 (). http://dx.doi.org/10.1016/j.cct.2021.106425

Peer Reviewed

1